Clinical Trial Update: Concurrent and Non-concurrent Chemo-radiotherapy or Radiotherapy Alone With Intensity-modulated Radiotherapy (IMRT) for Non Small Cell Lung Cancer (NSCLC) to an Individualised Mean Lung Dose (MLD) [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating concurrent and non-concurrent chemotherapy with radiotherapy, or radiotherapy alone, using intensity-modulated radiotherapy for Stage I…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: Maastricht Radiation Oncology | Conditions: Stage I-III Non-small Cell Lung Cancer | Phase 2 | Status: COMPLETED